GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2023-04-06| R&D

Mitochondria Transplantation May Improves Recovery after Cardiac Arrest

by Nai Ye Yeat
Share To

Mitochondria are organelles that act as the food-processing center of our cells. Recently, the team from the Feinstein Institutes for Medical Research has shown that mitochondria transplantation (MTx), the approach of delivering fresh mitochondria to critical tissues, can improve survival and neurological outcomes after cardiac arrest. 

Cardiac arrest is a life-threatening condition where a heart stops beating, the blood flow stops subsequently and the delivery of oxygen to the brain and other vital organs is blocked. This lethal condition of hypoxia will cause severe brain injury, but the quicker the heart can be restarted, the better prognosis will be expected.  

With the current approach, the overall survival of rats improved and the repair of the ischemic brain was accelerated according to the study published in the journal BMC Medicine.

Related Article: New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases

The Role of Mitochondria in Body Cells

Mitochondria are special organelles that have the ability to generate ATP with aerobic respiration, which requires oxygen, that’s why our cells need oxygen deliveries from blood. When oxygen delivery stops, mitochondria can no longer produce energy, and soon the cell is in danger of dying. Our brain, which controls fundamental parts of our body functions, is one of the organs which requires the most oxygen supply.

There is some past evidence showing mitochondria are able to assist in the repair of other mitochondria, for example, injured mitochondria are still capable of self-repair and cellular protection through fission, fusion, and mitophagy. The mechanisms of intercellular mitochondrial transfer were also shown to have protective effects in muscular tissues.  

A Novel Approach to Reverse Cells Damage

Thus, in this present study, the research team decided to test the effectiveness of transplantation in a cardiac arrest event with a specific focus on neuronal tissue health. The researchers first confirmed that donor mitochondria can be taken up by neurons growing in culture before attempting to transfer mitochondria into murine models. 

Mitochondria extracted from rat brain and muscle tissues were stained red and mitochondria of the neural cells were stained green. The donated mitochondria were taken up into cultured neural cells and co-localized with endogenous mitochondria inside neural cells. The in vivo test is then started after success in the cell model.

As a result, the 72-hour survival rate was 91% in freshly isolated mitochondria transplantation compared to just 55% in the negative control. Improvements in rapid recovery of arterial lactate, glucose levels, cerebral microcirculation, neurological function, and decreased lung injury were observed with improved survival rates. More importantly, as the frozen-thawed mitochondria did not have a protective effect, the mitochondrial activity from the fresh samples seems to be the key to the protective effect. 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
R&D
Novel Pathway for Metastatic Cancer Therapy: Targeting Mitochondrial Plasticity
2023-06-19
R&D
Geneticists Find Loss of Y Chromosome in Aging Males Increases Risk of Heart Failure
2022-07-20
Cancer Cells Build Nano-Highways to Hijack Mitochondria from Immune Cells
2021-11-25
LATEST
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation
2025-02-11
Trump’s Trade War Shake-Up: How U.S. Tariffs Could Disrupt Global Pharma
2025-02-10
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top